Physician profile
Gaurav Singal
NPI 1912227380
$798,309.45
in general payments reported to CMS, 2019-2025
8 companies · $113K in 2025
The $113K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $210K · 2022: $205K · 2023: $128K · 2024: $143K · 2025: $113K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $383K · Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $382,584.00 |
| Food and Beverage | $130.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | $502,694.00 | 2021-2025 | Clonoseq |
| Vertex Pharmaceuticals Incorporated | $180,000.00 | 2023-2024 | |
| Viz.Ai, INC. | $47,609.43 | 2021-2022 | |
| Caris Mpi, INC. | $45,000.00 | 2025 | Mi Cancer Seek |
| E.R. Squibb & Sons, L.L.C. | $22,646.63 | 2019-2022 | |
| Foundation Medicine, INC. | $229.00 | 2022 | |
| Abbvie INC. | $91.42 | 2024 | |
| Ge Healthcare | $38.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Singal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.